Sociedad Americana de Hirudoterapia

Culture, qPCR, and genome-based surveillance of,, andin school wastewater from Santiago, Chile.

Research article published in Frontiers in microbiology (2026)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportResistencia antimicrobianaGenómica y proteómicaEnsayos clínicosCortez-Astorga A et al. · Frontiers in microbiology, 2026

Abstract

BACKGROUND: Antimicrobial resistance (AMR) surveillance remains predominantly centered on clinical settings, potentially underestimating the community circulation of high-priority carbapenemase determinants. METHODS: We integrated culture-based isolation, absolute qPCR, and whole-genome sequencing (WGS) to monitor bla KPC , bla NDM , and bla VIM in school wastewater from Santiago, Chile. Four 8-h composite influent samples (one per season) were collected in 2024 from an educational establishment comprising primary and secondary levels. Wastewater was screened on MacConkey agar supplemented with ceftazidime or ciprofloxacin (2 μg/mL), followed by disk diffusion testing. Carbapenem-non-susceptible isolates were assessed by Blue-Carba and PCR targeting bla KPC , bla NDM , and bla VIM ; carbapenemase-confirmed isolates were further characterized by WGS and resistome analysis. In parallel, gene copy numbers were quantified directly from wastewater DNA using plasmid-based standard curves. RESULTS: Total bacterial recovery on antibiotic-free control plates was comparable across seasons, supporting consistent sampling performance. Resistance rates peaked in winter for both ceftazidime (3.7% ± 0.87) and ciprofloxacin (11.1% ± 1.72). Across seasons, 92 morphotypes were recovered, dominated by the genera Aeromonas (n = 43) and Pseudomonas (n = 17), with Enterobacterales most frequent in winter (10/18). Twenty-one isolates were non-susceptible to at least one carbapenem; 12 were Blue-Carba positive (winter, n = 9; fall, n = 3), while no carbapenem-resistant isolates were recovered in spring and no carbapenemase producers were detected in summer. Multi-carbapenemase genotypes were detected, with bla NDM restricted to winter. WGS confirmed bla KPC -bla NDM -bla VIM co-carriage in five winter isolates, including a critical-priority Escherichia coli ST1193. Genomes also revealed complex Aeromonas resistomes and the presence of mcr-1 and mcr-3.17 in Aeromonas allosaccharophila isolates. Absolute qPCR showed a pronounced winter peak (up to 107 copies for bla KPC ; >106 for bla NDM and bla VIM ) and low loads in spring-summer, mirroring isolate-based findings. CONCLUSIONS: School wastewater provided a sensitive community sentinel matrix for targeted carbapenemase surveillance, and bla KPC emerged as a robust biomarker capturing seasonal AMR dynamics.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article

Resumen

Antimicrobial resistance (AMR) surveillance remains predominantly centered on clinical settings, potentially underestimating the community circulation of high-priority carbapenemase determinants.

Por qué esto importa para la hirudoterapia

Este estudio de vigilancia ambiental combinó cultivo, PCR cuantitativa y secuenciación del genoma completo para rastrear genes de carbapenemasas (blaKPC, blaNDM, blaVIM) en aguas residuales escolares en Santiago, Chile, encontrando un marcado pico invernal en organismos resistentes a carbapenémicos, co-portación de múltiples genes de carbapenemasas en varios aislados y una recuperación notablemente alta del género Aeromonas. El hallazgo de Aeromonas es el hilo de relevancia para la hirudoterapia: Aeromonas (especialmente A. hydrophila/veronii) es el comensal principal del intestino de la sanguijuela medicinal y el organismo más asociado con infecciones de heridas post-sanguijuela, por lo que la evidencia comunitaria de que Aeromonas ambiental puede portar genes transmisibles de resistencia a carbapenémicos refuerza por qué la profilaxis antibiótica y la conciencia sobre la resistencia importan en la terapia con sanguijuelas. La advertencia clara es que este es un estudio de microbiología de aguas residuales/ambiental sobre la dinámica de la resistencia a los antimicrobianos (RAM) comunitaria, no un estudio clínico ni de hirudoterapia, y no extrae conclusiones sobre la infección o el tratamiento asociados a sanguijuelas.

Citación

Culture, qPCR, and genome-based surveillance of,, andin school wastewater from Santiago, Chile.

Cortez-Astorga A et al. · Frontiers in microbiology, 2026

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 28, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.